Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Myelodysplastic Syndromes and EPO[original query] |
---|
Cytogenetic abnormalities and genomic copy number variations in EPO (7q22) and SEC-61(7p11) genes in primary myelodysplastic syndromes. Blood cells, molecules & diseases 2016 Jul 59 52-7. Mohanty Purvi, Korgaonkar Seema, Shanmukhaiah Chandrakala, Ghosh Kanjaksha, Vundinti Babu R |
Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 4037-4042. Hattakitpanitchakul Saroj, Kobbuaklee Sirorat, Wudhikarn Kitsada, Polprasert Chanta |
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes. Therapeutic advances in hematology 2024 1 15 20406207231218157. Juan Carlos Caballero, Julio Dávila, María López-Pavía, Esperanza Such, Teresa Bernal, Fernando Ramos, Marisa Calabuig, Jesús María Hernández Sánchez, Helena Pomares, Mercedes Sánchez Barba, María Abáigar, Bernardo González, Brayan Merchán, Reyes Sancho-Tello, Marta Callejas, Carolina Muñoz-Novas, Carlos Cerveró, Guillermo Sanz, Jesús María Hernández Rivas, María Díez Campe |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: